Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Langdon

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Journal of Neuro-Oncology|August 9, 2019
Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)John D Hainsworth, Kevin P Becker, Tarek Mekhail, et al.
Haematologica|May 15, 2012
Late stage erythroid precursor production is impaired in mice with chronic inflammationOlivier D Prince, Jacqueline M Langdon, Andrew J Layman, et al.
Cancer|July 23, 2020
A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179Greg A Durm, Salma K Jabbour, Sandra K Althouse, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Journal of Neuro-Oncology|August 9, 2019
Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)John D Hainsworth, Kevin P Becker, Tarek Mekhail, et al.
Haematologica|May 15, 2012
Late stage erythroid precursor production is impaired in mice with chronic inflammationOlivier D Prince, Jacqueline M Langdon, Andrew J Layman, et al.
Cancer|July 23, 2020
A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non-small cell lung cancer: Hoosier Cancer Research Network LUN 14-179Greg A Durm, Salma K Jabbour, Sandra K Althouse, et al.
Pageof 8